Leading the way to safer medication
 Crosscheck  Recommender


Therapeutic Indications

Ambenonium is indicated for:

Myasthenia gravis

Irrespective of gender only Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral


Active ingredient Ambenonium is contraindicated in the following cases:

Contraindication 1

No gender/age discrimination